BSE Live
Jan 16, 16:01Prev. Close
1573.10
Open Price
1571.20
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Jan 16, 15:56Prev. Close
1570.60
Open Price
1575.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
1558.50 (586)
| Key Financial Ratios of Emcure Pharmaceuticals (in Rs. Cr.) | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | |
| Per Share Ratios | ||||||
| Basic EPS (Rs.) | 9.69 | 15.68 | 13.42 | 12.01 | 17.58 | |
| Diluted EPS (Rs.) | 9.69 | 15.68 | 13.42 | 12.01 | 17.58 | |
| Cash EPS (Rs.) | 18.26 | 22.86 | 20.06 | 18.41 | 23.36 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 105.86 | 98.29 | 78.00 | 67.84 | 60.13 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 105.86 | 98.29 | 78.00 | 67.84 | 60.13 | |
| Dividend / Share(Rs.) | 2.50 | 3.50 | 3.50 | 1.50 | 10.00 | |
| Revenue from Operations/Share (Rs.) | 131.36 | 135.67 | 123.94 | 113.78 | 118.16 | |
| PBDIT/Share (Rs.) | 31.02 | 36.56 | 32.55 | 29.77 | 34.94 | |
| PBIT/Share (Rs.) | 22.45 | 29.39 | 25.91 | 23.37 | 29.17 | |
| PBT/Share (Rs.) | 12.42 | 20.45 | 18.94 | 12.38 | 21.97 | |
| Net Profit/Share (Rs.) | 9.69 | 15.68 | 13.42 | 12.01 | 17.58 | |
| Profitability Ratios | ||||||
| PBDIT Margin (%) | 23.61 | 26.95 | 26.26 | 26.16 | 29.57 | |
| PBIT Margin (%) | 17.09 | 21.65 | 20.90 | 20.53 | 24.68 | |
| PBT Margin (%) | 9.45 | 15.07 | 15.27 | 10.87 | 18.59 | |
| Net Profit Margin (%) | 7.37 | 11.56 | 10.83 | 10.55 | 14.87 | |
| Return on Networth / Equity (%) | 9.15 | 15.95 | 17.21 | 17.69 | 29.23 | |
| Return on Capital Employed (%) | 16.29 | 23.06 | 25.17 | 24.78 | 32.96 | |
| Return on Assets (%) | 4.52 | 7.92 | 7.75 | 8.01 | 12.22 | |
| Total Debt/Equity (X) | 0.53 | 0.55 | 0.65 | 0.68 | 0.71 | |
| Asset Turnover Ratio (%) | 0.64 | 0.73 | 0.77 | 0.78 | 0.91 | |
| Liquidity Ratios | ||||||
| Current Ratio (X) | 1.31 | 1.29 | 0.99 | 1.00 | 1.11 | |
| Quick Ratio (X) | 0.99 | 0.90 | 0.62 | 0.46 | 0.59 | |
| Inventory Turnover Ratio (X) | 1.19 | 1.10 | 0.72 | 0.60 | 0.91 | |
| Dividend Payout Ratio (NP) (%) | 25.80 | 28.69 | 22.34 | 12.49 | 24.88 | |
| Dividend Payout Ratio (CP) (%) | 13.69 | 19.68 | 14.95 | 8.14 | 18.73 | |
| Earnings Retention Ratio (%) | 74.20 | 71.31 | 77.66 | 87.51 | 75.12 | |
| Cash Earnings Retention Ratio (%) | 86.31 | 80.32 | 85.05 | 91.86 | 81.27 | |
| Valuation Ratios | ||||||
| Enterprise Value (Cr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| EV/Net Operating Revenue (X) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| EV/EBITDA (X) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| MarketCap/Net Operating Revenue (X) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Retention Ratios (%) | 74.19 | 71.30 | 77.65 | 87.50 | 75.11 | |
| Price/BV (X) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Price/Net Operating Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Earnings Yield | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
09.01.2026
07.01.2026
24.12.2025
10.12.2025
17.11.2025
Emcure Pharmace Consolidated September 2025 Net Sales at Rs 2,269.82 crore, up 13.38% Y-o-Y
12.11.2025
Emcure Pharmace Standalone September 2025 Net Sales at Rs 1,260.60 crore, up 14.12% Y-o-Y
07.08.2025
Emcure Pharmace Standalone June 2025 Net Sales at Rs 1,096.57 crore, up 13.01% Y-o-Y
27.05.2025
Emcure Pharmace Consolidated March 2025 Net Sales at Rs 2,116.25 crore, up 19.47% Y-o-Y